Cargando…

Thrombotic risk determined by rare and common SERPINA1 variants in a population‐based cohort study

BACKGROUND: Severe alpha‐1‐antitrypsin deficiency (AATD), phenotype PiZZ, was associated with venous thromboembolism (VTE) in a case‐control study. OBJECTIVES: This study aimed to determine the genetic variation in the SERPINA1 gene and a possible thrombotic risk of these variants in a population‐ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manderstedt, Eric, Halldén, Christer, Lind‐Halldén, Christina, Elf, Johan, Svensson, Peter J., Engström, Gunnar, Melander, Olle, Baras, Aris, Lotta, Luca A., Zöller, Bengt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	THROMBOSIS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314614/ https://www.ncbi.nlm.nih.gov/pubmed/35263815 http://dx.doi.org/10.1111/jth.15696

Ejemplares similares

Classic Thrombophilias and Thrombotic Risk Among Middle‐Aged and Older Adults: A Population‐Based Cohort Study
por: Manderstedt, Eric, et al.
Publicado: (2022)

Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle‐aged and older adults: A population‐based cohort study
por: Manderstedt, Eric, et al.
Publicado: (2022)

Contribution of rare and common coding variants to haematological malignancies in the UK biobank
por: Zöller, Bengt, et al.
Publicado: (2023)

Contribution of rare genetic variants to heart failure and cardiomyopathy in the UK Biobank
por: Zöller, Bengt, et al.
Publicado: (2023)

Rare-variant collapsing analyses of arterial hypertension in the UK biobank
por: Zöller, Bengt, et al.
Publicado: (2023)

Bioinformatic and rare‐variant collapsing analyses for type 1 and type 2 diabetes in the UK Biobank reveal novel pleiotropic susceptibility loci
por: Zöller, Bengt, et al.
Publicado: (2023)

Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2020)

Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening
por: Manderstedt, Eric, et al.
Publicado: (2019)

Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR
por: Manderstedt, Eric, et al.
Publicado: (2020)

Sex‐Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population‐Based Historical Cohort Study of Middle‐Aged and Older Individuals
por: Brink, Annie, et al.
Publicado: (2023)

Genetic variation of the Toll-like receptors in a Swedish allergic rhinitis case population
por: Henmyr, V., et al.
Publicado: (2017)

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022)

The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer
por: Zhu, Shuhao, et al.
Publicado: (2020)

Chronic Rhinosinusitis Patients Show Accumulation of Genetic Variants in PARS2
por: Henmyr, Viktor, et al.
Publicado: (2016)

Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
por: Knoebl, Paul, et al.
Publicado: (2019)

Post‐thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study
por: de Kleijn, Robert J. C. M. F., et al.
Publicado: (2022)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura
por: Borogovac, Azra, et al.
Publicado: (2022)

The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Bissola, Anna-Lise, et al.
Publicado: (2022)

Vaccine-Induced Thrombotic Thrombocytopenia: Novelty Testing in the Diagnostic Work-up?
por: Cacciola, Rossella Rosari, et al.
Publicado: (2021)

Gene variance in the nicotinic receptor cluster (CHRNA5‐CHRNA3‐CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers
por: Halldén, S., et al.
Publicado: (2015)

The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients
por: Zheng, Rena, et al.
Publicado: (2021)

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
por: Schönborn, Linda, et al.
Publicado: (2022)

Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV
por: Al Raizah, Abdulrahman, et al.
Publicado: (2021)

Lupus anticoagulant test persistence over time and its associations with future thrombotic events
por: Colling, Meaghan E., et al.
Publicado: (2022)

Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura
por: Shin, Jin-Sup, et al.
Publicado: (2022)

Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review
por: Yu, Philip, et al.
Publicado: (2021)

A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Lee, Christine S.M., et al.
Publicado: (2022)

A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
por: Falter, Tanja, et al.
Publicado: (2023)

A Rare Case of Mild COVID-19 Disease Associated with Type 1 Cryoglobulinemia and Thrombotic Thrombocytopenic Purpura
por: Naqvi, Syed Mujtaba, et al.
Publicado: (2021)

COVID-19 Diagnosis and Its Impact on Thrombotic Risk in a Cohort of Patients Simultaneously Hospitalized Due to Acute Respiratory Distress Syndrome
por: Coy-Canguçu, Andréa, et al.
Publicado: (2021)

Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura
por: Westwood, John-Paul, et al.
Publicado: (2014)

Psychological stress and risk of incident atrial fibrillation in men and women with known atrial fibrillation genetic risk scores
por: Svensson, Thomas, et al.
Publicado: (2017)

A genetic risk score for CAD, psychological stress, and their interaction as predictors of CAD, fatal MI, non-fatal MI and cardiovascular death
por: Svensson, Thomas, et al.
Publicado: (2017)

Causal Effect of Adiposity Measures on Blood Pressure Traits in 2 Urban Swedish Cohorts: A Mendelian Randomization Study
por: Giontella, Alice, et al.
Publicado: (2021)

Characteristics of pain, other symptoms and function in pediatric post‐thrombotic syndrome
por: Avila, Maria L., et al.
Publicado: (2018)

Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
por: Stals, Milou A. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d8hjpauv6u01fqi36gkochn2gf